AI-assisted clinical summary and treatment planning for cancer care: A comparative study of human vs. AI-based approaches.
Po-Hsuan Cameron Cameron Chen, Han‐Byoel Lee(Seoul National University Hospital), Ji-Jung Jung, Rodrigo Sánchez-Bayona(Research Institute Hospital 12 de Octubre), Houda Bahig(Centre Hospitalier de l’Université de Montréal), Matthew J. Cecchini(Western University), Paul J. Bröckelmann(University Hospital Cologne), Michael Yan(University of Toronto), Joseph Y. Cheng, Denise Bernhardt(Heidelberg University), William R. Polkinghorn, David A. Palma(Western University), Minjung Lee(Chosun University), Robert Olson(BC Cancer Agency), Yoona Kim(University of South Australia), Petros Giannikopoulos(University of California, San Francisco), Christopher D. Goodman(London Health Sciences Centre), Sherman Lin
Cited by 4
Related Papers
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
|The Lancet|2019|1.9k
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
|Journal of Clinical Oncology|2020|1.3k
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study
|Journal of Clinical Oncology|2019|1.3k
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study
|The Lancet Oncology|2016|1.1k
Predicting Radiation Pneumonitis After Chemoradiation Therapy for Lung Cancer: An International Individual Patient Data Meta-analysis
|International Journal of Radiation Oncology*Biology*Physics|2013|673